QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2015     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Role for engagement of-arrestin2 by the transactivated EGFR in agonist-specific regulation of receptor activation of ERK1/2 期刊论文 BRITISH JOURNAL OF PHARMACOLOGY, 2015, 卷号: 172, 期号: 20, 页码: 4847-4863 作者:  Zhang, Le-Sha;  Wang, Yu-Jun;  Ju, Yun-Yue;  Zan, Gui-Ying;  Xu, Chi 收藏  |  浏览/下载：19/0  |  提交时间：2019/01/08 Diabetic cardiomyopathy: Role of epidermal growth factor receptor tyrosine kinase 期刊论文 JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2015, 卷号: 84 作者:  Xu, Zheng;  Cai, Lu 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05 SYNERGISTIC EFFECT OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN EGFR-TKI RESISTANT NON-SMALL CELL LUNG CANCER CELL LINES 会议论文 ANNALS OF ONCOLOGY, 2015-04-01 作者:  Han, X.;  Zhang, N.;  Yao, J.;  Shi, Y. 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/04 SYNERGISTIC EFFECT OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN EGFR-TKI RESISTANT NON-SMALL CELL LUNG CANCER CELL LINES 期刊论文 2015, 卷号: 26 作者:  Han, X.;  Zhang, N.;  Yao, J.;  Shi, Y. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 Patient Characteristics and Treatment Outcome of Advanced Non-Squamous NSCLC with over 6-Month Disease Control from Icotinib 期刊论文 2015, 卷号: 10, 期号: 9, 页码: S653-S653 作者:  Yang, Sheng;  Hu, Xingsheng;  Li, Junling;  Wang, Ziping;  Wang, Yan 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 Epidermal growth factor receptor tyrosine kinase inhibitor  icotinib  Brain metastasis   Antitumor Efficacy of Histone Deacetylase Inhibitor or in Combination with EGFR-TKI in Non-Small Cell Lung Cancer Cell Lines 期刊论文 2015, 卷号: 10, 期号: 9, 页码: S484-S484 作者:  Han, Xiaohong;  Zhang, Ningning;  Yao, Jiarui;  Shi, Yuankai 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Epidermal growth factor receptor tyrosine kinase inhibitor  non-small cell lung cancer  histone deacetylase inhibitor  antitumor efficacy   Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients 期刊论文 2015, 卷号: 89, 期号: 3, 页码: 337-342 作者:  Shan, Ling;  Wang, Ziping;  Guo, Lei;  Sun, Hongyan;  Qiu, Tian 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 Lung adenocarcinoma  Epidermal growth factor receptor  Mutation  Gene amplification  Tyrosine kinase inhibitor  Tumor heterogeneity